News and Views

Radiation therapy

Rural Patients Who Miss Radiation Doses Are More Likely to Die From Cancer

Regardless of residence, nearly 25% of patients with cancer overall miss at least 10% of the doses in their radiation treatment plans—but the implications on outcomes are far greater for patients living in rural areas than their urban counterparts, according to new research findings published in the International Journal of Radiation Oncology, Biology, Physics.

December 28, 2022

Trending Topics

View All Topics

Oncology APRNs Are Change Agents for Tobacco Cessation

Advanced Practice Nursing (APRN)

Oncology APRNs Are Change Agents for Tobacco Cessation

December 27, 2022

Redefining the Bell Makes the Ritual Inclusive for All Patients With Cancer

Patient empowerment

Redefining the Bell Makes the Ritual Inclusive for All Patients With Cancer

December 23, 2022

FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer

December 22, 2022

Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage

Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage

December 21, 2022

Oncology Drug Reference Sheet: Dostarlimab-Gxly

Drug Reference Sheet

Oncology Drug Reference Sheet: Dostarlimab-Gxly

December 20, 2022

FDA Approves Updated Drug Labeling Including New Indications and Dosing Regimens for Capecitabine Tablets Under Project Renewal

U.S. Food and Drug Administration (FDA)

FDA Approves Updated Drug Labeling Including New Indications and Dosing Regimens for Capecitabine Tablets Under Project Renewal

December 16, 2022

Wrap Up the Year With Reflection and Gratitude

Nurse well-being

Wrap Up the Year With Reflection and Gratitude

December 15, 2022

FDA Grants Accelerated Approval to Adagrasib for KRAS G12C–Variant Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Adagrasib for KRAS G12C–Variant Non-Small Cell Lung Cancer

December 14, 2022

New Cancer Drugs Launch at Record-High Prices

Prescription medication

New Cancer Drugs Launch at Record-High Prices

December 14, 2022

Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

Patient financial advocacy

Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

December 13, 2022

FDA Approves Atezolizumab for Alveolar Soft Part Sarcoma

U.S. Food and Drug Administration (FDA)

FDA Approves Atezolizumab for Alveolar Soft Part Sarcoma

December 13, 2022

Overcome Inequalities in Cancer Treatment Options Across the Ages

Cancer treatments

Overcome Inequalities in Cancer Treatment Options Across the Ages

December 13, 2022

Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients

Nurse navigator

Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients

December 08, 2022

Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care

End of life (EOL)

Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care

December 07, 2022

Travel Nurses Bring Beneficial and Important Skills for Patient Care

Oncology nursing roles

Travel Nurses Bring Beneficial and Important Skills for Patient Care

December 06, 2022

Nontraditional Oncology Nursing Roles

Oncology nursing roles

Nontraditional Oncology Nursing Roles

December 06, 2022

$FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukemia With Susceptible IDH1 Variants$

U.S. Food and Drug Administration (FDA)

FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukemia With Susceptible IDH1 Variants

December 05, 2022

Join Us in Celebrating All That ONS Members Helped Us Achieve in 2022

Join Us in Celebrating All That ONS Members Helped Us Achieve in 2022

December 05, 2022

Genetic Disorder Reference Sheet: HOXB13

Genetics & genomics

Genetic Disorder Reference Sheet: HOXB13

November 30, 2022

Help Your Patients Prepare for the End From the Beginning

Help Your Patients Prepare for the End From the Beginning

November 24, 2022

Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk

Prostate cancer

Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk

November 23, 2022

FDA Approves Second Dosing Regimen for Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn

U.S. Food and Drug Administration (FDA)

FDA Approves Second Dosing Regimen for Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn

November 22, 2022

Give Thanks for Your Well-Being With Healthy Recipes for Your Holiday Gatherings

Nurse well-being

Give Thanks for Your Well-Being With Healthy Recipes for Your Holiday Gatherings

November 22, 2022

Oncology Drug Reference Sheet: Tebentafusp-Tebn When the U.S. Food and Drug Administration (FDA) approved tebentafusp-tebn (Kimmtrak®) in January 2022 as an orphan drug for unresectable or metastatic uveal melanoma (mUM) in adults, it became the first—and only, at the time of this reference sheet’s publication—drug approved for the indication.

Drug Reference Sheet

Oncology Drug Reference Sheet: Tebentafusp-Tebn

November 22, 2022

FDA Approves Brentuximab Vedotin in Combination With Chemotherapy for Pediatric Patients With Classical Hodgkin Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Brentuximab Vedotin in Combination With Chemotherapy for Pediatric Patients With Classical Hodgkin Lymphoma

November 16, 2022

FDA Grants Accelerated Approval to Mirvetuximab Soravtansine-Gynx for FR Alpha–Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Mirvetuximab Soravtansine-Gynx for FR Alpha–Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

November 16, 2022

Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks

Cancer treatments

Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks

November 16, 2022

What the Evidence Says About Probiotics and Cancer Immunotherapy

What the Evidence Says About Probiotics and Cancer Immunotherapy

November 15, 2022

FDA Approves Tremelimumab in Combination With Durvalumab and Platinum-Based Chemotherapy for Metastatic Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Tremelimumab in Combination With Durvalumab and Platinum-Based Chemotherapy for Metastatic Non-Small Cell Lung Cancer

November 11, 2022

NOBC Partnerships Advance Nurses’ Placements on Local and National Boards

Oncology nurse influence

NOBC Partnerships Advance Nurses’ Placements on Local and National Boards

November 10, 2022

PARP Inhibitors and Ovarian Cancer

PARP Inhibitors and Ovarian Cancer

November 10, 2022

Biomarkers Are Associated With Frailty After Chemo for Breast Cancer

Biomarkers Are Associated With Frailty After Chemo for Breast Cancer

November 09, 2022

Educational Resources Will Help Biomarkers Have Even More Impact

Nursing education

Educational Resources Will Help Biomarkers Have Even More Impact

November 08, 2022

Predictive and Diagnostic Biomarkers

Care coordination

Predictive and Diagnostic Biomarkers

November 08, 2022

Let Your Voice Be Heard as an Oncology Nurse Advocate

Let Your Voice Be Heard as an Oncology Nurse Advocate

November 07, 2022

Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy

Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy

November 03, 2022

FDA Recommends Reusing Tracheostomy Tubes or Switching to Appropriate Alternatives Because of Shortage

U.S. Food and Drug Administration (FDA)

FDA Recommends Reusing Tracheostomy Tubes or Switching to Appropriate Alternatives Because of Shortage

November 02, 2022

FDA Recommends Healthcare Providers Consider Alternatives for MRI-Guided Breast Biopsy Grid Plates Because of Shortage

U.S. Food and Drug Administration (FDA)

FDA Recommends Healthcare Providers Consider Alternatives for MRI-Guided Breast Biopsy Grid Plates Because of Shortage

November 02, 2022

Most Lung Cancer Genetic Variants Are Clinically Actionable and All Patients Should Get Biomarker Testing

Cancer research

Most Lung Cancer Genetic Variants Are Clinically Actionable and All Patients Should Get Biomarker Testing

November 02, 2022

Genetic Counselors Help Patients and Oncology Nurses Predict Current and Future Cancer Diagnoses

Genetics & genomics

Genetic Counselors Help Patients and Oncology Nurses Predict Current and Future Cancer Diagnoses

November 01, 2022

Color Out Your Stress and Anxiety

Nurse well-being

Color Out Your Stress and Anxiety

October 27, 2022

$FDA Approves Teclistamab-Cqyv for Relapsed or Refractory Multiple Myeloma$

U.S. Food and Drug Administration (FDA)

FDA Approves Teclistamab-Cqyv for Relapsed or Refractory Multiple Myeloma

October 26, 2022

Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance

Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance

October 26, 2022

FDA Approves Tremelimumab in Combination With Durvalumab for Unresectable Hepatocellular Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Tremelimumab in Combination With Durvalumab for Unresectable Hepatocellular Carcinoma

October 25, 2022

Oncology Drug Reference Sheet: Asparaginase Erwinia Chrysanthemi (Recombinant)–Rywn

Drug Reference Sheet

Oncology Drug Reference Sheet: Asparaginase Erwinia Chrysanthemi (Recombinant)–Rywn

October 25, 2022

Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer

Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer

October 19, 2022

Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer

Sexual/reproductive issues

Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer

October 18, 2022

Exela Pharma Sciences, LLC, Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection Because of Vial Breakage

U.S. Food and Drug Administration (FDA)

Exela Pharma Sciences, LLC, Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection Because of Vial Breakage

October 14, 2022

New SIO-ASCO Guideline Identifies Integrative Care Recommendations for Cancer-Related Pain

Pain management

New SIO-ASCO Guideline Identifies Integrative Care Recommendations for Cancer-Related Pain

October 14, 2022

Back to Top ▲